Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descriptive Analysis of First-Cycle Prophylactic Use of G-CSF in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated With High Neutropenia Risk Chemotherapy

NCT02921191 is registered in ClinicalTrials.gov with Biologics & Biosimilars Collective Intelligence Consortium as lead sponsor.

NCT NCT02921191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02921191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descriptive Analysis of First-Cycle Prophylactic Use of G-CSF in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated With High Neutropenia Risk Chemotherapy
Lead sponsor
Biologics & Biosimilars Collective Intelligence Consortium
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
February 28, 2019
Enrollment
57,725 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer